4DX.AX
4DMEDICAL FPO [4DX]
A$3.97
+18.86%
2026-05-29
About 4DMEDICAL FPO [4DX]
4DMedical Limited operates as a medical technology company in the United States and Australia. The company engages in the medical research technology and development of a non-invasive respiratory imaging solution using four-dimensional imaging. It offers CT:VQ, non contrast post processing technology; CAC, a non-contrast cardiothoracic risk assessment sotware; CT LVAS, a regional lung function imaging software; IQ-UIP, a state-of-the-art software; LDAf, Patented Parametric Response Mapping (PRM) technology; LDAi, an automated detection of potential emphysema software; LTA provides visualization and quantification of the lung textures; PHA Analysis, a cutting-edge, fully-automated imaging solution; XV LVAS, a lung airflow imaging software; and XV Scanner, a lung function scanner. The company was incorporated in 2012 and is based in Carlton, Australia.
Key Fundamentals
Forward P/E
-106.23
EPS (TTM)
A$-0.40
ROE
-1099.3%
Revenue Growth (YoY)
-1.5%
Profit Margin
0.0%
Debt/Equity
6.71
Price/Book
28.99
Beta
1.97
Market Cap
A$2.35B
Avg Volume (10D)
7.8M
Recent Breakout Signals
No recent breakout signals detected for 4DX.AX.
Recent Price Range (60 Days)
60D High
A$7.55
60D Low
A$3.09
Avg Volume
8.3M
Latest Close
A$3.97
Get breakout alerts for 4DX.AX
Sign up for Breakout Scanner to receive daily notifications when 4DX.AX triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
4DMEDICAL FPO [4DX] (4DX.AX) is listed on the Australian Securities Exchange (ASX). Breakout Scanner monitors 4DX.AX daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. 4DX.AX operates in the Healthcare sector within the Medical Devices industry. Data is provided for informational purposes only and does not constitute financial advice.